ERRα expression is dysregulated in several types of carcinoma including colon, endometrium, ovary, breast and prostate cancer, and its high expression levels correlate closely with poor patient outcomes in lung adenocarcinoma [56]. The gene discussed is ESRRA; the disease is prostate cancer.